Accelerating your Electronic Product Information (ePI) journey
Supporting you to deliver a more cost effective, accessible, sustainable and competitive patient experience with an end-to-end suite of services, underpinned by our proprietary ePI technology platform.
The challenge
Digitising product information is rapidly rising to the top of the agenda for pharmaceutical companies. It’s better for the planet. Better for patients. Better for operating costs. And regulation to support the move to Electronic Product Information (ePI) is just around the corner.
In a world where patients increasingly rely on digital technologies, Paper Information Leaflets (PILs) are no longer fit for purpose. They are not easily updated, they often pose a language barrier and whilst more than half of patients want more information(1), they’re not clear where to find it. Demand is building for a digital solution.
The current paper format creates frustration for manufacturers too. How can you enhance patient interaction with important product information when you have little visibility over how patients are engaging with this content today? By digitising product information, manufacturers gain access to untapped data and insight with the potential to improve patient outcomes and inform product strategy in a way that creates market advantage.
Beyond the benefits for patients and manufacturers, the transition to digital is a real win for the planet. Today, it is estimated that removing PILs across the EU could save approximately 700,000 tonnes of carbon dioxide equivalent(2). Reducing the reliance on paper is one simple way for businesses to limit the environmental impact of their supply chains and reach their net zero goals.
The solution
The move to ePI can feel daunting. Managing medical products globally is complex due to varying regulations, differing health care systems, and vast numbers of SKUs to handle. It also impacts many business areas, including Regulatory Affairs, Operations, Supply Chain, Commercial, Corporate and Sustainability. Wherever you are operating, the need to digitise is clear. But where do you begin?
Deloitte offers end-to-end transformation solutions to support you on your ePI journey. From helping you to build an initial business case for change, to redesigning and transforming your operating model, through to implementing and running your entire ePI technology solution at global scale. Our services are underpinned by Deloitte’s proprietary ePI platform, helping to accelerate your transformation.
Our industry experts work alongside you every step of the way, helping you navigate the changing regulatory landscape, ensuring you embrace every sustainability opportunity and sharing their deep sector knowledge to always keep you one step ahead.
Benefits
Reduce your operating costs
We will work with you to reduce or eliminate the need to produce paper leaflets, redesign packaging and artwork, ensuring a significant cost reduction.
Progress net-zero ambitions
You will work alongside our sustainability experts to ensure that all opportunities to help reach net-zero targets and improve circularity are harnessed, measured and realised.
Support regulatory compliance
Our regulatory and industry experts will help you to navigate the ever-changing ePI legislative environment, and our AI solutions help you structure and migrate your content to FHIR standard.
Access our strong ecosystem
We bring together leading technology organisations to build and deliver robust solutions that align to your strategic technology imperatives.
Invaluable patient insights
Our usage analytics and insights team build dashboards to help inform your commercial strategies and drive revenue growth.
Increase speed to market
We help to enable regulator collaboration, supporting quicker regulatory review and label updates, resulting in medicines being made available quicker to patients. We have a range of assets ready to be deployed, all created by our industry experts and designers who specialise in user-first, inclusive experiences.
Address the digital divide
Our solutions are carefully designed in a variety of formats to ensure they work for all patients. They can be customised, accessed in different languages and linked to further resources, helping patients stay better informed and potentially supporting adherence to medication.
Accelerate transition to FHIR
We use generative AI to transform any of your semi structured ePI data or unstructured documents (e.g. pdf) into FHIR data correctly aligned to industry systems, all controlled under Deloitte’s AI governance and risk management frameworks. This accelerates transition to FHIR specification as the market is moving to structured data.
Opens in new window
How we can help
Whilst we offer a full end-to-end transformation service, we will work with you to understand your business needs and where required offer a flexible modular approach.
1. Strategy and business case: We work with you to build the case for change and identify benefits of moving to ePI.
2. Prototype and concept work: We bring the ePI vision to life - gaining insight and showcasing how it can work in your operation.
3. Operating model transformation: We imagine and design new or updated structures, capabilities, and operational processes to make ePI a reality.
4. Implementation and scale: We will implement the Global Enterprise-wide roll-out of ePI, covering detailed design, system build and integration, global roll-out, and associated training and mobilisation.
5. Migration: As part of the implementation, we will migrate your global, diverse PI data to FHIR standard, and ensure it generates ePI.
6. Running your ePI solution: We don't just stop at design and build. We can manage your full ePI solution, including analytics, support, service and content updates and QA services.
Reference
Get in touch
Opens in new window